Boston Trust Walden Corp increased its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 87.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 482,323 shares of the company's stock after buying an additional 225,389 shares during the period. Boston Trust Walden Corp's holdings in Procter & Gamble were worth $82,197,000 at the end of the most recent reporting period.
Several other large investors also recently made changes to their positions in PG. NewSquare Capital LLC lifted its position in Procter & Gamble by 933.3% in the 4th quarter. NewSquare Capital LLC now owns 155 shares of the company's stock valued at $26,000 after acquiring an additional 140 shares in the last quarter. Navigoe LLC bought a new position in Procter & Gamble in the 4th quarter valued at about $31,000. Capital A Wealth Management LLC bought a new position in Procter & Gamble in the 4th quarter valued at about $31,000. Hoey Investments Inc. lifted its position in shares of Procter & Gamble by 321.7% during the 4th quarter. Hoey Investments Inc. now owns 194 shares of the company's stock worth $33,000 after buying an additional 148 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA bought a new position in shares of Procter & Gamble during the 4th quarter worth approximately $34,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Price Performance
Shares of PG traded up $0.91 during mid-day trading on Friday, reaching $158.93. 16,056,110 shares of the stock traded hands, compared to its average volume of 7,417,131. Procter & Gamble Company has a 1 year low of $156.58 and a 1 year high of $180.43. The company has a current ratio of 0.71, a quick ratio of 0.50 and a debt-to-equity ratio of 0.47. The company has a market cap of $372.62 billion, a price-to-earnings ratio of 25.23, a price-to-earnings-growth ratio of 4.66 and a beta of 0.43. The firm has a fifty day moving average price of $163.51 and a 200 day moving average price of $166.25.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The company reported $1.54 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.53 by $0.01. Procter & Gamble had a net margin of 18.46% and a return on equity of 32.67%. The company had revenue of $19.78 billion during the quarter, compared to the consensus estimate of $20.42 billion. During the same period in the previous year, the firm posted $1.52 EPS. The firm's revenue was down 2.1% compared to the same quarter last year. As a group, equities research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Monday, April 21st were issued a dividend of $1.0568 per share. This is an increase from Procter & Gamble's previous quarterly dividend of $1.01. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.66%. The ex-dividend date of this dividend was Monday, April 21st. Procter & Gamble's payout ratio is currently 67.14%.
Wall Street Analysts Forecast Growth
PG has been the topic of several recent analyst reports. Barclays reissued an "equal weight" rating on shares of Procter & Gamble in a research report on Thursday, March 27th. Bank of America dropped their target price on shares of Procter & Gamble from $190.00 to $180.00 and set a "buy" rating on the stock in a research report on Friday, April 25th. Erste Group Bank cut shares of Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. JPMorgan Chase & Co. decreased their price target on shares of Procter & Gamble from $181.00 to $172.00 and set an "overweight" rating for the company in a research note on Friday, April 11th. Finally, Royal Bank Of Canada upgraded shares of Procter & Gamble from a "sector perform" rating to an "outperform" rating and lifted their price objective for the company from $164.00 to $177.00 in a research note on Friday, April 25th. Eight equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $178.86.
Get Our Latest Stock Analysis on PG
Insider Transactions at Procter & Gamble
In other news, insider Moses Victor Javier Aguilar sold 10,520 shares of Procter & Gamble stock in a transaction on Monday, May 5th. The shares were sold at an average price of $158.67, for a total transaction of $1,669,208.40. Following the completion of the sale, the insider now directly owns 25,182 shares of the company's stock, valued at approximately $3,995,627.94. The trade was a 29.47% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Jennifer L. Davis sold 1,000 shares of the business's stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total transaction of $161,380.00. Following the completion of the sale, the chief executive officer now directly owns 51,965 shares of the company's stock, valued at $8,386,111.70. This represents a 1.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.18% of the stock is currently owned by insiders.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.